Ionis Pharmaceuticals, Inc. (IONS)
60.36
-0.69
(-1.13%)
USD |
NASDAQ |
Aug 31, 16:00
60.35
-0.01
(-0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Research and Development Expense (Annual) : 913.18M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 913.18M |
| December 31, 2024 | 901.53M |
| December 31, 2023 | 899.62M |
| December 31, 2022 | 833.15M |
| December 31, 2021 | 643.45M |
| December 31, 2020 | 535.08M |
| December 31, 2019 | 465.17M |
| December 31, 2018 | 413.36M |
| December 31, 2017 | 374.00M |
| December 31, 2016 | 341.78M |
| December 31, 2015 | 317.50M |
| December 31, 2014 | 239.51M |
| December 31, 2013 | 181.57M |
| December 31, 2012 | 157.64M |
| December 31, 2011 | 155.50M |
| December 31, 2010 | 143.66M |
| December 31, 2009 | 134.62M |
| December 31, 2008 | 106.44M |
| Date | Value |
|---|---|
| December 31, 2007 | 92.64M |
| December 31, 2006 | 80.57M |
| December 31, 2005 | 72.78M |
| December 31, 2004 | 106.30M |
| December 31, 2003 | 104.71M |
| December 31, 2002 | 113.77M |
| December 31, 2001 | 83.74M |
| December 31, 2000 | 57.01M |
| December 31, 1999 | 66.41M |
| December 31, 1998 | 57.94M |
| December 31, 1997 | 52.76M |
| December 31, 1996 | 43.02M |
| December 31, 1995 | 30.36M |
| December 31, 1994 | 22.61M |
| December 31, 1993 | 22.37M |
| December 31, 1992 | 21.63M |
| December 31, 1991 | 11.44M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Biogen, Inc. | 1.481B |
| BridgeBio Pharma, Inc. | 451.95M |
| Vertex Pharmaceuticals, Inc. | 3.754B |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |